Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression

NCT: NCT06132581 · RECRUITING

NCT IDNCT06132581
StatusRECRUITING
Start Date2024-01-24
Completion2027-07-31
SponsorFlorida State University (OTHER)
First posted
Last updated

Brief Summary

Anhedonia, the inability to seek-out and experience pleasure, is a common symptom in depression that predicts treatment-resistance and is sometimes exacerbated by first-line antidepressants. In our previous research, we found that anhedonia decreases goal-directed behavior and its related neural activity. In this study, we will investigate target engagement from five-consecutive days of stimulation for participants that are within a unipolar major depressive episode and also have high symptoms of anhedonia.

Frequently Asked Questions

What is Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression?

Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression is a clinical trial registered under NCT06132581. Current status: RECRUITING.

What is the status of NCT06132581?

The current status of NCT06132581 (Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression) is: RECRUITING.

When did Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression start?

Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression started on 2024-01-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.